Your email has been successfully added to our mailing list.

×
0 0 0 0.00253807106598991 -0.0101522842639593 -0.032994923857868 -0.0456852791878172 -0.0583502538071065
Stock impact report

TapImmune's T-cell vaccine candidate TPIV200 shows encouraging action in early-stage cancer study; shares ahead 16% premarket [Seeking Alpha]

TAPIMMUNE INC COMMON (TPIV) 
NASDAQ:AMEX Investor Relations: tapimmune.com/investors
Company Research Source: Seeking Alpha
TapImmune's T-cell vaccine candidate TPIV200 shows encouraging action in early-stage cancer study; shares ahead 16% premarketThinly traded nano cap TapImmune (NASDAQ:TPIV) is up16% premarket on modestly higher volume in response to itsannouncement of positive results from a Phase 1 clinical trial assessing T-cell vaccine candidate TPIV200 in patients with ovarian and breast cancer. The data were just published in the journalClinical Cancer Research.TPIV200 was well-tolerated by all patients and over 90% developed robust and durable antigen-specific immune responses against a protein calledfolate receptor alpha which is overexpressed in a range of cancers. Although the 10-subject trial was not powered for efficacy, the observed median progression-free survival (PFS) was 528 days, significantly above ~313 days for standard-of-care treatment.A Phase 2 study in women with platinum-sensitive ovarian cancer is ongoing. Interim data should be available in mid-2019.See all stocks on the move Show less Read more
Impact Snapshot
Event Time:
TPIV
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
Last price at news event
Since Event
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
Last Price
VWAP
High:
Max Up
High:
Low:
Max Down
Low:
%
Post news range
%
Price change

Price Change Percentage


S&P 500
(SPX)

%

Volume ratio
%

Volume
Ticks

Avg transaction size

Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Opt-in for TPIV alerts
Opt-in for
TPIV alerts

from News Quantified
Opt-in for
TPIV alerts

from News Quantified